13F HOLDINGS REPORT
Finepoint Capital LP
Quarter ended Q3 2023 · Filed August 11, 2023 · Accession 0000904454-23-000482
Total Value
$289.1M
Positions
37
Other Managers
0
Confidential Omitted
No
Holdings (37)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APELLIS PHARMACEUTICALS INC | APLS | 241,690 | $22.0M | 7.62% |
| 2 | PROTHENA CORP PLC | PRTA | 317,300 | $21.7M | 7.50% |
| 3 | ACADIA PHARMACEUTICALS INC | ACAD | 846,953 | $20.3M | 7.02% |
| 4 | SAGE THERAPEUTICS INC | 78667J108 | 357,765 | $16.8M | 5.82% |
| 5 | AMICUS THERAPEUTICS INC | FOLD | 1,325,775 | $16.7M | 5.76% |
| 6 | GALAPAGOS NV | GLPGF | 406,859 | $16.5M | 5.72% |
| 7 | MORPHIC HOLDING INC | 61775R105 | 287,556 | $16.5M | 5.70% |
| 8 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 608,628 | $16.0M | 5.52% |
| 9 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 492,545 | $15.7M | 5.42% |
| 10 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 302,000 | $15.4M | 5.33% |
| 11 | CRINETICS PHARMACEUTICALS IN | CRNX | 797,527 | $14.4M | 4.97% |
| 12 | SAREPTA THERAPEUTICS INC | SRPT | 125,457 | $14.4M | 4.97% |
| 13 | ASCENDIS PHARMA A/S | ASND | 139,772 | $12.5M | 4.32% |
| 14 | CYTOKINETICS INC | CYTK | 369,093 | $12.0M | 4.17% |
| 15 | CLARIVATE PLC | CLVT | 1,247,406 | $11.9M | 4.11% |
| 16 | TRAVERE THERAPEUTICS INC | TVTX | 761,721 | $11.7M | 4.05% |
| 17 | ARVINAS INC | ARVN | 411,500 | $10.2M | 3.53% |
| 18 | BAUSCH HEALTH COS INC | 071734107 | 1,165,000 | $9.3M | 3.22% |
| 19 | RELAY THERAPEUTICS INC | RLAY | 701,570 | $8.8M | 3.05% |
| 20 | SOLID BIOSCIENCES INC | SLDB | 961,251 | $5.0M | 1.74% |
| 21 | ARES ACQUISITION CORP | G33032122 | 504,706 | $403,765 | 0.14% |
| 22 | BRIDGETOWN HOLDINGS LTD | G1355U121 | 895,000 | $221,960 | 0.08% |
| 23 | CHURCHILL CAPITAL CORP V | 17144T115 | 612,000 | $110,221 | 0.04% |
| 24 | CHURCHILL CAPITAL CORP VI | 17143W119 | 540,000 | $97,200 | 0.03% |
| 25 | FIRST LIGHT ACQUISITION GROUP INC | CLDWW | 655,200 | $85,176 | 0.03% |
| 26 | CHURCHILL CAPITAL CORP VII | 17144M110 | 548,000 | $76,720 | 0.03% |
| 27 | ROSS ACQUISITION CORP II | G7641C114 | 439,666 | $74,435 | 0.03% |
| 28 | COMPASS DIGITAL ACQUISITION CORP | COMP | 459,906 | $68,434 | 0.02% |
| 29 | SWIFTMERGE ACQUISITION CORP | G63836111 | 490,000 | $48,020 | 0.02% |
| 30 | MARBLEGATE ACQUISITION CORP | 56608A113 | 735,000 | $41,307 | 0.01% |
| 31 | AFTERNEXT HEALTHTECH ACQUISITION CORP | G01109126 | 366,666 | $31,753 | 0.01% |
| 32 | CONYERS PARK III ACQUISITION CORP | 21289P110 | 571,666 | $28,583 | 0.01% |
| 33 | YS BIOPHARMA CO LTD | G9845F117 | 489,999 | $23,030 | 0.01% |
| 34 | CONCORD ACQUISITION CORP II | CNDAW | 408,333 | $16,333 | 0.01% |
| 35 | HOME PLATE ACQUISITION CORP | 43734R111 | 690,000 | $14,697 | 0.01% |
| 36 | BILANDER ACQUISITION CORP | 09001T114 | 183,749 | $9,334 | 0.00% |
| 37 | CORSAIR PARTNERING CORP | G2540H116 | 334,666 | $0 | 0.00% |